HealthcareTransaction activity across the Healthcare sector remains strong.
Deal volumes are being driven by new technology, new care delivery models, new investors entering the market and the need for more to be achieved from the NHS budget.
At Catalyst we segment the sector into three key areas – Healthcare Services, Pharmaceuticals (products and services) and Medtech (devices and supplies). Within these we are seeing strong interest and have deal experience in:
- Contract research organisation services
- Domiciliary and specialist care
- Generic pharmaceuticals
- Primary and Community Care services
- Telecare devices and services
The inaugural Catalyst Pharma Fast 50, our list of the 50 fastest-growing privately owned pharmaceutical companies in the UK in 2016
Adobe Acrobat file - 3.4 mb
The emergence of US trade buyers has energised the exit environment for owner managers and investors. We expect further consolidation over the next few years.
Adobe Acrobat file - 0.7 mb
The past twelve months have seen a continuation of strong overall healthcare activity. Deal volumes across each sector have risen with pharmaceuticals recording a significant increase.
Adobe Acrobat file - 1.4 mb